Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation
- PMID: 7637017
- PMCID: PMC189431
- DOI: 10.1128/JVI.69.9.5716-5722.1995
Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation
Erratum in
- J Virol 1997 Jul;71(7):5712
Abstract
We have analyzed the roles of Gag protein nucleocapsid (NC) domains in the packaging or encapsidation of retroviral RNAs into virus particles. We found that mutation of both zinc finger motifs of the human immunodeficiency virus (HIV) NC domain reduced but did not eliminate encapsidation of the HIV viral RNA. However, the NC mutations also resulted in a three- to fourfold reduction in the specificity of RNA encapsidation, as determined by comparison of virus-associated genomic and spliced RNA levels. As a complementary approach, we replaced the NC domain of Moloney murine leukemia virus (M-MuLV) with that of HIV. Chimeric virus particles assembled efficiently, were of wild-type M-MuLV density, and cross-linked at NC cysteines. In encapsidation studies, wild-type M-MuLV precursor Gag (PrGag) proteins packaged M-MuLV transcripts more efficiently than HIV RNAs. In contrast, chimeric PrGag proteins possessing the HIV-1 NC domain in the context of the M-MuLV MA (matrix), p12, and CA (capsid) domains encapsidated HIV transcripts to a greater extent than M-MuLV transcripts. Our results support the notion that retroviral NC domains contribute toward both the efficiency and specificity of viral genomic RNA packaging.
Similar articles
-
Retroviral nucleocapsid domains mediate the specific recognition of genomic viral RNAs by chimeric Gag polyproteins during RNA packaging in vivo.J Virol. 1995 Oct;69(10):6445-56. doi: 10.1128/JVI.69.10.6445-6456.1995. J Virol. 1995. PMID: 7666546 Free PMC article.
-
Nucleocapsid and matrix protein contributions to selective human immunodeficiency virus type 1 genomic RNA packaging.J Virol. 1998 Mar;72(3):1983-93. doi: 10.1128/JVI.72.3.1983-1993.1998. J Virol. 1998. PMID: 9499052 Free PMC article.
-
The zinc finger of nucleocapsid protein of Friend murine leukemia virus is critical for proviral DNA synthesis in vivo.J Virol. 1996 Sep;70(9):5791-8. doi: 10.1128/JVI.70.9.5791-5798.1996. J Virol. 1996. PMID: 8709195 Free PMC article.
-
Nucleic acid chaperone activity of retroviral Gag proteins.RNA Biol. 2010 Nov-Dec;7(6):700-5. doi: 10.4161/rna.7.6.13685. Epub 2010 Nov 1. RNA Biol. 2010. PMID: 21045546 Free PMC article. Review.
-
Diverse interactions of retroviral Gag proteins with RNAs.Trends Biochem Sci. 2011 Jul;36(7):373-80. doi: 10.1016/j.tibs.2011.04.001. Epub 2011 May 6. Trends Biochem Sci. 2011. PMID: 21550256 Free PMC article. Review.
Cited by
-
HIV-1 RNA genome packaging: it's G-rated.mBio. 2024 Apr 10;15(4):e0086123. doi: 10.1128/mbio.00861-23. Epub 2024 Feb 27. mBio. 2024. PMID: 38411060 Free PMC article. Review.
-
Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.Protein Sci. 2001 Jul;10(7):1434-45. doi: 10.1110/ps.52601. Protein Sci. 2001. PMID: 11420445 Free PMC article.
-
Genetic evidence for a connection between Rous sarcoma virus gag nuclear trafficking and genomic RNA packaging.J Virol. 2009 Jul;83(13):6790-7. doi: 10.1128/JVI.00101-09. Epub 2009 Apr 15. J Virol. 2009. PMID: 19369339 Free PMC article.
-
Nucleocapsid protein function in early infection processes.Virus Res. 2008 Jun;134(1-2):39-63. doi: 10.1016/j.virusres.2007.12.006. Epub 2008 Feb 14. Virus Res. 2008. PMID: 18279991 Free PMC article. Review.
-
cis-active structural motifs involved in specific encapsidation of Moloney murine leukemia virus RNA.J Virol. 1996 Aug;70(8):5043-50. doi: 10.1128/JVI.70.8.5043-5050.1996. J Virol. 1996. PMID: 8764011 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials